Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dunkel

Showing results (231-240 of 237) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 237 results.
Neuro-Oncology|February 11, 2022
Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patientsAlexandra M Miller, Luca Szalontay, Nancy Bouvier, et al.
The Lancet. Oncology|June 2, 2019
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trialJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Nature Medicine|November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2024
Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology GroupMichael R Sargen, Raymond L Barnhill, David E Elder, et al.
Nature Cancer|July 26, 2021
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumorsElise M Fiala, Gowtham Jayakumaran, Audrey Mauguen, et al.
JCO Precision Oncology|September 14, 2020
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF InhibitionLiana Nobre, Michal Zapotocky, Vijay Ramaswamy, et al.
Cancer Discovery|April 3, 2020
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable OutcomesMatthew Clarke, Alan Mackay, Britta Ismer, et al.
Pageof 24

Showing results (231-240 of 237) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 237 results.
Neuro-Oncology|February 11, 2022
Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patientsAlexandra M Miller, Luca Szalontay, Nancy Bouvier, et al.
The Lancet. Oncology|June 2, 2019
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trialJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Nature Medicine|November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2024
Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology GroupMichael R Sargen, Raymond L Barnhill, David E Elder, et al.
Nature Cancer|July 26, 2021
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumorsElise M Fiala, Gowtham Jayakumaran, Audrey Mauguen, et al.
JCO Precision Oncology|September 14, 2020
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF InhibitionLiana Nobre, Michal Zapotocky, Vijay Ramaswamy, et al.
Cancer Discovery|April 3, 2020
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable OutcomesMatthew Clarke, Alan Mackay, Britta Ismer, et al.
Pageof 24